心力衰竭诊断与管理的进展及挑战
Advances and Challenges in Diagnosis and Management of Heart Failure.
作者信息
Sullivan Ryan D, Gladysheva Inna P
机构信息
Department of Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
出版信息
Diagnostics (Basel). 2022 Apr 28;12(5):1103. doi: 10.3390/diagnostics12051103.
Abstract
The prevalence of heart failure (HF) with reduced (r) and preserved (p) ejection fraction (EF) continues to rise globally despite current advances in diagnostics and improvements to medical management [...].
摘要
尽管目前在诊断方面取得了进展，医疗管理也有所改善，但全球射血分数降低（r）和保留（p）的心衰（HF）患病率仍在持续上升[……]
相似文献
1
Advances and Challenges in Diagnosis and Management of Heart Failure.心力衰竭诊断与管理的进展及挑战
Diagnostics (Basel). 2022 Apr 28;12(5):1103. doi: 10.3390/diagnostics12051103.
2
Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.心力衰竭伴射血分数降低与心力衰竭伴射血分数保留患者焦虑的预后价值。
J Am Heart Assoc. 2019 Jun 18;8(12):e010739. doi: 10.1161/JAHA.118.010739. Epub 2019 Jun 11.
3
Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA.成纤维细胞生长因子 23 与射血分数降低型和射血分数保留型心力衰竭：MESA 研究。
J Am Heart Assoc. 2018 Sep 18;7(18):e008334. doi: 10.1161/JAHA.117.008334.
4
Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.运动对射血分数保留型心力衰竭与射血分数降低型心力衰竭患者左心室收缩和舒张功能的影响。
Circ Heart Fail. 2013 May;6(3):508-16. doi: 10.1161/CIRCHEARTFAILURE.112.000216. Epub 2013 Mar 20.
5
Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.射血分数改善的心力衰竭的特征、结局和治疗。
J Am Heart Assoc. 2019 Mar 19;8(6):e011077. doi: 10.1161/JAHA.118.011077.
6
[Chronic heart failure].[慢性心力衰竭]
Cas Lek Cesk. 2015;154(6):260-8.
7
Heart Failure: Heart Failure With Preserved Ejection Fraction.心力衰竭：射血分数保留的心力衰竭。
FP Essent. 2021 Jul;506:11-19.
8
Inflammatory pathways in patients with heart failure and preserved ejection fraction.射血分数保留的心力衰竭患者的炎症通路
Int J Cardiol. 2008 Sep 16;129(1):111-7. doi: 10.1016/j.ijcard.2007.05.061. Epub 2007 Jul 20.
9
Heart Failure with Recovered EF and Heart Failure with Mid-Range EF: Current Recommendations and Controversies.射血分数恢复的心力衰竭和射血分数中等范围的心力衰竭：当前建议与争议
Curr Treat Options Cardiovasc Med. 2018 Apr 3;20(4):35. doi: 10.1007/s11936-018-0628-9.
10
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.心力衰竭伴左心室射血分数保留患者住院趋势：患病率、治疗方法和结局。
Circulation. 2012 Jul 3;126(1):65-75. doi: 10.1161/CIRCULATIONAHA.111.080770. Epub 2012 May 21.
本文引用的文献
1
Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion.钠-葡萄糖协同转运蛋白2抑制剂通过减轻水肿和充血改善射血分数降低的心力衰竭结局。
Diagnostics (Basel). 2022 Apr 14;12(4):989. doi: 10.3390/diagnostics12040989.
2
Association of Non-Alcoholic Fatty Liver Disease and Hepatic Fibrosis with Epicardial Adipose Tissue Volume and Atrial Deformation Mechanics in a Large Asian Population Free from Clinical Heart Failure.在一个无临床心力衰竭的大型亚洲人群中，非酒精性脂肪性肝病和肝纤维化与心外膜脂肪组织体积及心房变形力学的关联
Diagnostics (Basel). 2022 Apr 6;12(4):916. doi: 10.3390/diagnostics12040916.
3
Prediction of Adverse Post-Infarction Left Ventricular Remodeling Using a Multivariate Regression Model.使用多变量回归模型预测心肌梗死后左心室不良重塑
Diagnostics (Basel). 2022 Mar 21;12(3):770. doi: 10.3390/diagnostics12030770.
4
Echocardiographic Parameters as Predictors for the Efficiency of Resynchronization Therapy in Patients with Dilated Cardiomyopathy and HFrEF.超声心动图参数作为扩张型心肌病和射血分数降低的心力衰竭患者心脏再同步治疗疗效的预测指标
Diagnostics (Basel). 2021 Dec 24;12(1):35. doi: 10.3390/diagnostics12010035.
5
The Role of Echocardiography in the Management of Heart Transplant Recipients.超声心动图在心脏移植受者管理中的作用
Diagnostics (Basel). 2021 Dec 11;11(12):2338. doi: 10.3390/diagnostics11122338.
6
Chronic Kidney Disease and Heart Failure-Everyday Diagnostic Challenges.慢性肾脏病与心力衰竭——日常诊断挑战
Diagnostics (Basel). 2021 Nov 22;11(11):2164. doi: 10.3390/diagnostics11112164.
7
A Multivariate Model to Predict Chronic Heart Failure after Acute ST-Segment Elevation Myocardial Infarction: Preliminary Study.预测急性ST段抬高型心肌梗死后慢性心力衰竭的多变量模型：初步研究
Diagnostics (Basel). 2021 Oct 18;11(10):1925. doi: 10.3390/diagnostics11101925.
8
Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus.2型糖尿病患者样本中血清生物标志物成纤维细胞生长因子21、半乳糖凝集素-3和 copeptin 对射血分数保留的心力衰竭的诊断性能
Diagnostics (Basel). 2021 Aug 30;11(9):1577. doi: 10.3390/diagnostics11091577.
9
Pulmonary Congestion Assessment in Heart Failure: Traditional and New Tools.心力衰竭中的肺充血评估：传统工具与新工具
Diagnostics (Basel). 2021 Jul 21;11(8):1306. doi: 10.3390/diagnostics11081306.
10
Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges.用于急性心肌梗死诊断的血液生物标志物的过去、现在与未来——前景与挑战
Diagnostics (Basel). 2021 May 15;11(5):881. doi: 10.3390/diagnostics11050881.
Zotero 插件